Endothelial-derived microparticles (EMPs) are a novel biological marker of endothelium
injury and vasomotion disorders that are involved in pathogenesis of cardiovascular …

Heart failure is a class of cardiovascular diseases that remains the number one cause of
death worldwide with a substantial economic burden of around $18 billion incurred by the …

Importance Depression is frequent in patients with heart failure and is associated with
adverse clinical outcomes. Long-term efficacy and safety of selective serotonin reuptake …

Objective Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous
syndrome. We aimed to derive HFpEF phenotype-based groups ('phenogroups') based on …

New parameters and markers are constantly being sought to help better assess patients with
heart failure (HF). ST2 protein has gained interest as a potential biomarker in cardiovascular …

Background Chronic heart failure (CHF) has been remained a leading cause of
cardiovascular morbidity and mortaluty. The risk stratification of CHF individuals based on …

Objectives: The aim of this study was to investigate whether echocardiographic assessment
of myocardial work is a predictor of outcome in advanced heart failure. Background: Global …

Aim Identification of patients with heart failure and a poor prognosis is paramount to ensure
timely and adequate treatment. We investigated the relationship between the new measures …

Purpose Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for
cardiovascular diseases. The aim of the study was to assess the influence of OSAS on …

Background The B-type natriuretic peptides are now available on many automated clinical
analysers. Clinical practice guidelines for heart failure include recommendations for where …